1. One should not just read what one believes: the nearly irresolvable issue of producing truly objective, evidence-based guidelines for the management of differentiated thyroid cancer

   • Markus Dietlein
   • F. A. Verburg
   • H. Schicha

   Editorial 18 January 2011 Pages: 793 - 798

2. PET/CT for staging lung cancer: costly or cost-saving?

   • Andreas K. Buck
   • Ken Herrmann
   • Jonas Schreyögg

   Editorial Commentary 26 March 2011 Pages: 799 - 801

3. Preoperative staging of lung cancer with PET/CT: cost-effectiveness evaluation alongside a randomized controlled trial

   • Rikke Søgaard
   • Barbara Malene B. Fischer
   • Ulrik Lassen

   Original Article 06 January 2011 Pages: 802 - 809

   

4. FDG PET/CT patterns of treatment failure of malignant pleural mesothelioma: relationship to histologic type, treatment algorithm, and survival

   • Victor H. Gerbaudo
   • Marcelo Mamede
   • David J. Sugarbaker

   Original Article 06 January 2011 Pages: 810 - 821

   

5. PET/CT in malignant melanoma: contrast-enhanced CT versus plain low-dose CT

   • Thomas Pfluger
   • Henriette Ingrid Melzer
   • Mayo Weiss

   Original Article 06 January 2011 Pages: 822 - 831

   

6. Measuring response to therapy using FDG PET: semi-quantitative and full kinetic analysis

   • Patsuree Cheebsumon
   • Linda M. Velasquez
   • Ronald Boellaard

   Original Article Open access 06 January 2011 Pages: 832 - 842

   

7. Optimal gating compared to 3D and 4D PET reconstruction for characterization of lung tumours

   • Wouter van Elmpt
   • James Hamill
   • Michel Öllers

   Original Article Open access 11 January 2011 Pages: 843 - 855

   

8. Impact of rigid and nonrigid registration on the determination of ¹⁸F-FDG PET-based tumour volume and standardized uptake value in patients with lung cancer

   • Aleksandar Grgic
   • Elena Ballek
   • Dirk Hellwig

   Original Article 22 January 2011 Pages: 856 - 864

   

9. Functional imaging in phaeochromocytoma and neuroblastoma with ⁶⁸Ga-DOTA-Tyr³-octreotide positron emission tomography and ¹²³I-metaiodobenzylguanidine

   • Alexander Kroiss
   • Daniel Putzer
   • Irene Johanna Virgolini

   Original Article 29 January 2011 Pages: 865 - 873

   

10. Bio-effect model applied to ¹³¹I radioimmunotherapy of refractory non-Hodgkin’s lymphoma

    • Peter L. Roberson
    • Hanan Amro
    • Yuni K. Dewaraja

    Original Article 21 December 2010 Pages: 874 - 883

    

11. Bone metabolic activity in hyperostosis cranialis interna measured with ¹⁸F-fluoride PET

    • Jérôme J. Waterval
    • Thijs M. A. Van Dongen
    • Johannes J. Manni

    Original Article Open access 16 November 2010 Pages: 884 - 893

    

12. Duration of ¹⁸F-FDG avidity in lymph nodes after pandemic H1N1v and seasonal influenza vaccination

    • Anders Thomassen
    • Anne Lerberg Nielsen
    • Henrik Petersen

    Original Article 22 February 2011 Pages: 894 - 898

    

13. ^99mTc-besilesomab (Scintimun®) in peripheral osteomyelitis: comparison with ^99mTc-labelled white blood cells

    • Wolf S. Richter
    • Velimir Ivancevic
    • Alberto Signore

    Original Article Open access 15 February 2011 Pages: 899 - 910

    

14. Quantification of neutrophil migration into the lungs of patients with chronic obstructive pulmonary disease

    • Prina Ruparelia
    • Katherine R. Szczepura
    • Edwin R. Chilvers

    Original Article 10 February 2011 Pages: 911 - 919

    

15. The effect of patient positioning aids on PET quantification in PET/MR imaging

    • Frederic Mantlik
    • Matthias Hofmann
    • Thomas Beyer

    Original Article 10 February 2011 Pages: 920 - 929

    

16. Automatic generation of absolute myocardial blood flow images using [¹⁵O]H₂O and a clinical PET/CT scanner

    • Hendrik J. Harms
    • Paul Knaapen
    • Mark Lubberink

    Original Article Open access 27 January 2011 Pages: 930 - 939

    

17. Effect of the positron range of ¹⁸F, ⁶⁸Ga and ¹²⁴I on PET/CT in lung-equivalent materials

    • Gerrit J. Kemerink
    • Mariëlle G. W. Visser
    • Gerrit J. J. Teule

    Original Article 02 February 2011 Pages: 940 - 948

    

18. In vivo imaging of immune cell trafficking in cancer

    • Luisa Ottobrini
    • Cristina Martelli
    • Giovanni Lucignani

    Review Article 18 December 2010 Pages: 949 - 968

    

19. Molecular imaging of atherosclerosis in translational medicine

    • Pasquale Perrone-Filardi
    • Santo Dellegrottaglie
    • Alberto Cuocolo

    Review Article 21 December 2010 Pages: 969 - 975

    

20. Multimodality Imaging Training Curriculum – General Recommendations

    • European Association of Nuclear Medicine (EANM)
    • European Society of Radiology (ESR)

    Special Contribution 29 March 2011 Pages: 976 - 978

21. Does hybrid diagnostic imaging in cardiology have the same significance as in oncology?

    • Panagiotis Georgoulias
    • Ioannis Tsougos
    • Nikolaos Demakopoulos

    Letter to the Editor 19 February 2011 Pages: 979 - 981

22. Wandering spleen on a ⁶⁸Ga-DOTATOC-PET/CT scan

    • Nele Lips
    • Christophe M. Deroose
    • Luc Mortelmans

    Image of the Month 13 January 2011 Pages: 982 - 982

23. FDG PET coregistered to MRI for diagnosis and monitoring of therapeutic response in aggressive phenotype of sarcoidosis

    • Alessio Imperiale
    • Sophie Riehm
    • Jean-Jacques Braun

    Image of the Month 29 January 2011 Pages: 983 - 984

    

24. EANM Marie-Curie Training Project Report 2011 University Medical Centre Charité Berlin Ivayla Apostolova

    Society communications 02 April 2011 Pages: 985 - 986